Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review

November 2021 | 45 pages | ID: PE038276C0AEN
GlobalData

Abstracts

Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Physiomics plc (Physiomics) provides consulting services to pharmaceutical companies in the areas of computational biology and quantitative pharmacology. It has proprietary technology platform, Virtual Tumour, which uses computer modelling to predict the effects of cancer drugs and treatments. The company offers model based drug development services, which includes population (Pharmacokinetics and Pharmacodynamics) PKPD analysis of clinical data, back-translational analysis, and optimal design of future studies. It also has Quantitative Systems Pharmacology which involves combination of PK/PD of a therapeutic agent with the mechanistic model and a large quantitative experimental drug data. Physiomics is headquartered at Oxford, the UK.

Physiomics Plc Key Recent Developments

Oct 22,2021: Physiomics: Contract awards
Sep 30,2021: Physiomics Announces Final Results for the year ended 30 June 2021 and Date of AGM
Sep 30,2021: Full year results presentation YE 30 Jun 2021 and update on TabulaRasa Healthcare collaboration
Sep 30,2021: Physiomics Announces Final Results For the Year 30 June 2021
Sep 30,2021: Physiomics Announces Date of AGM

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Physiomics Plc - Key Facts
Physiomics Plc - Key Employees
Physiomics Plc - Key Employee Biographies
Physiomics Plc - Major Products and Services
Physiomics Plc - History
Physiomics Plc - Company Statement
Physiomics Plc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Physiomics Plc - Business Description
Physiomics Plc - Corporate Strategy
Physiomics Plc - SWOT Analysis
SWOT Analysis - Overview
Physiomics Plc - Strengths
Physiomics Plc - Weaknesses
Physiomics Plc - Opportunities
Physiomics Plc - Threats
Physiomics Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Physiomics Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Oct 22, 2021: Physiomics: Contract awards
Sep 30, 2021: Physiomics Announces Final Results for the year ended 30 June 2021 and Date of AGM
Sep 30, 2021: Full year results presentation YE 30 Jun 2021 and update on TabulaRasa Healthcare collaboration
Sep 30, 2021: Physiomics Announces Final Results For the Year 30 June 2021
Sep 30, 2021: Physiomics Announces Date of AGM
Sep 15, 2021: Physiomics to Announce results for the full year ending 30 June 2021
Aug 31, 2021: Physiomics hires Head of Business Development
Jul 19, 2021: Physiomics expands technical team
May 21, 2021: Physiomics: Contract awards with Bicycle Therapeutics
May 14, 2021: Physiomics announces contract award

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Physiomics Plc, Key Facts
Physiomics Plc, Key Employees
Physiomics Plc, Key Employee Biographies
Physiomics Plc, Major Products and Services
Physiomics Plc, History
Physiomics Plc, Key Competitors
Physiomics Plc, Ratios based on current share price
Physiomics Plc, Annual Ratios
Physiomics Plc, Annual Ratios (Cont...1)
Physiomics Plc, Interim Ratios
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Physiomics Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Physiomics Plc, Performance Chart (2017 - 2021)
Physiomics Plc, Ratio Charts
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Physiomics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021